Skip to main content
Equibles
OCGN logo

OCGN · Ocugen, Inc.

Track OCGN — free Ask ALVIS about OCGN
$1.30 -0.01 (-0.76%) At close · Aug 5
Going-concern doubt — flagged May 8, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result of these factors, together with the anticipated continued spending that will be necessary to continue to research, develop, and commercialize the Company's product candidates, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued.”
View the 10-Q filed May 8, 2026
Market Cap
$423.15M
Shares
338.52M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.31 Open$1.28 Day$1.24–1.33 52W$0.93–2.73 Avg vol 30d7.4M Short int100.6M · 29.7% float · 18.9d Short vol62% Last earningsMay 5, 2026 DataJan 2020–Aug 2026 Filing10-Q · May 8

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 8, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Very Bullish Fundamentals Fair Quant / Vol Very High
      Market backdrop VIX 15.8 · calm Equity put/call 0.46
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −14%
      below
      Price vs 50-day avg −3%
      below
      RSI (14) 49
      neutral
      MACD trend Negative
      52-week position 21%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −13%
      trailing
      6-month return −8%
      trailing
      YTD return −3%
      this year
      Relative strength −19%
      vs S&P · 6-mo
      Sentiment
      smart money
      Very Bullish
      Trend (MA cross) No cross
      50d $1 › 200d $2 — 200d above 50d
      Institutional flow Accumulating
      41 of 136 funds reported for Jun 30 · net +1.1M sh shares · +11 new
      Insider flow Accumulating
      Net +$25.8K over 90 days · 0% sells
      Short interest Falling
      29.71% of float · ▼ -4.6% MoM · 18.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      136 holders — near 3-yr high, broad support
      Squeeze score 78
      high risk · 0–100
      Fundamentals
      Fair
      Revenue growth −100%
      Y/Y
      EPS growth +35%
      Y/Y
      Free cash flow $-57.1M
      Balance sheet $10.7M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 80%
      annualized · 1-yr
      Max drawdown −52%
      past year
      ATR 6.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Sell
      2 · 5 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −14% Bearish
      Price vs 50-day avg
      −3% Neutral
      RSI (14)
      49 Neutral
      MACD trend
      Negative Bearish
      52-week position
      21% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 4 of 6
      Trend (MA cross) No cross
      50d $1 › 200d $2 — 200d above 50d
      Institutional flow Accumulating
      41 of 136 funds reported for Jun 30 · net +1.1M sh shares · +11 new
      Insider flow Accumulating
      Net +$25.8K over 90 days · 0% sells
      Short interest Falling
      29.71% of float · ▼ -4.6% MoM · 18.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      136 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $1 Now $1 · 21% 52-wk high $3
      vs 200-day avg -14% vs 50-day avg -3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      shares of common stock outstanding 312.4M as of December 31, 2025 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      OCGN
      Ocugen, Inc.
      this stock
      		$423.15M -3.0% -32.8% — 29.7%
      ONC
      BeOne Medicines Ltd.
      		 $453.48B +6.3% +22179.2% 697.3 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $119.47B +5.6% +46.2% 27.5 2.0%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $78.17B -1.2% +20.8% 18.8 3.4%
      ARGX
      Argenx SE
      		 $54.30B +3.2% — — 2.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      141
      % held
      33.7%
      Reported
      41 of 136
      Top holder
      VANGUARD CAPITAL MANAGEME…
      Held Float
      View
      Held by Funds
      Fund positions
      32
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      100.6M
      Days to cover
      18.9d
      Change
      -4.8M sh
      View
      Short Volume
      Short vol %
      62%
      As of
      Aug 5, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      189.4K
      Value
      $267.0K
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      51.5%
      Week of
      Jun 29, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$25.8K
      Buyers / Sellers
      1 / 0
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Christopher L. Jacobs
      Amount
      $1.0K–$15.0K
      Traded
      Nov 8, 2022
      View
      Financials
      Financials
      Revenue (FY)
      $4.4M
      Net income (FY)
      $-67.8M
      EPS diluted
      $-0.26
      View
      Filings
      SEC Filings
      Latest
      DEF 14A
      Filed
      Jul 30, 2026
      This year
      22
      View
      Proposed Sales
      Value
      $122.9K
      Shares
      112.2K
      Filed
      Jul 9, 2025
      View
      Exempt Offerings
      Offering
      $395
      Filed
      May 7, 2020
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jun 4, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      OCGN +5.7% -12.7% -7.8% +6.5% -3.0%
      SPY +4.1% +3.2% +11.4% +3.3% +13.1%
      vs SPY +1.5% -15.8% -19.2% +3.3% -16.1%
      Key facts CIK 1372299 CUSIP 67577C105 13F (30d) 34 filings 34 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)